1. From the Health Economics Research Unit, University of Aberdeen (VW, MR), Aberdeen, Clinical Effectiveness Unit, Royal College of Surgeons (CTB, ME) and Institute of Urology (CTB, ME), London, GlaxoSmithKline Research and Development (GB), Brentford and Department of Urology, Ashford St Peter's Hospital (BWE), Middlesex, United Kingdom